Ads
related to: ceftaroline fosamil warnings for prostate cancer treatment options bcg- Dosing & Administration
Learn About Dosing Considerations
For This Targeted Treatment.
- Access Information
Find Resources For Your Patients
With Advanced Prostate Cancer.
- Physician Resources
Download The Patient Brochure &
Other Helpful Resources Here.
- Efficacy Information
Physicians, See How A Targeted
Treatment May Help Your Patients.
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Ceftaroline fosamil / s ɛ f ˈ t ær oʊ l iː n /, brand name Teflaro in the US and Zinforo in Europe, [1] [2] is a cephalosporin antibiotic with anti-MRSA activity. [3] Ceftaroline fosamil is a prodrug of ceftaroline. It is active against methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive bacteria.
Prostate cancer: Myelosuppression, diarrhoea, kidney failure, hypersensitivity, severe GI reactions (including perforation, ileus, colitis, etc.; all rare) and peripheral neuropathy Docetaxel: IV: As above. Breast cancer, non-small cell lung cancer, ovarian cancer, prostate cancer, squamous cell head and neck cancer and gastric cancer.
Surgical removal of the prostate, or prostatectomy, is a common treatment either for early-stage prostate cancer or for cancer that has failed to respond to radiation therapy. The most common type is radical retropubic prostatectomy , when the surgeon removes the prostate through an abdominal incision.
PSA levels between 4 and 10 suggest you could have about a 25 percent chance of prostate cancer, and levels over 10 signal that your chance of having the cancer is more than 50 percent.
Granulomatous prostatitis is an uncommon disease of the prostate, an exocrine gland of the male reproductive system. [1] It is a form of prostatitis (prostate inflammation), resulting from infection (bacterial, viral, or fungal), BCG vaccine , malacoplakia or systemic granulomatous diseases which involve the prostate.
CAR-T treatment generally involves extracting disease-fighting white blood cells known as T-cells from a patient, re-engineering them to attack cancer and infusing them back into the body.
Ads
related to: ceftaroline fosamil warnings for prostate cancer treatment options bcg